在NSCLC的进展和对治疗的反应中,瘤和微环境的交叉交互
Zahraa Rahal1, Roy El Darzi2, Seyed Javad Moghaddam3,4
1Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. zrahal@mdanderson.org.
Nature reviews. Clinical oncology
|May 16, 2025
概括
瘤微环境 (TME) 显著影响非小细胞肺癌 (NSCLC) 的进展和治疗反应. 了解TME的复杂性是开发新疗法和改善患者治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 非小细胞肺癌 (NSCLC) 的治疗正在通过向药物和免疫疗法迅速推进.
- 然而,低于最佳的治疗反应需要新的治疗策略.
- 瘤微环境 (TME) 在NSCLC进展,转移和治疗疗效方面发挥着关键作用.
研究的目的:
- 提供关于NSCLC TME的全面概述.
- 探索NSCLC TME中的组件,原型和相互作用.
- 讨论患者因素和治疗策略对TME的影响.
主要方法:
- 关于NSCLC TME的当前文献的审查.
- 对TME组件,空间和原型的分析.
- 检查TME相互作用,包括炎症和免疫抑制.
- 考虑与患者相关的因素 (老龄化,性别,健康差异).
- 在TME的背景下讨论治疗策略.
主要成果:
- NSCLC TME包括由不同的空间所形成的复杂的社区.
- 炎症和免疫抑制是塑造TME的关键动态.
- 老龄化,性别和健康差异等患者因素会影响TME交叉通话.
- 治疗策略与TME密切相关,并受到TME的影响.
结论:
- 了解多面性NSCLC TME对于改善当前治疗方法和克服耐药性至关重要.
- TME组件,患者因素和治疗的相互联系决定了治疗结果和瘤进展.
- 准TME为开发下一代NSCLC疗法提供了有前途的途径.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...


